Resources

With the Covid-19 outbreak having caused significant disruption to healthcare services, including those for hepatitis C, this webinar was organised to discuss how services have been affected in different areas across the country and explore how hepatitis C services can most effectively be re-established as we emerge from the early phase of the outbreak. The webinar featured contributions from the following speakers: • Mark Gillyon-Powell - Head of Programme, HCV Elimination, NHS England & NHS Improvement • Dr Steve Ryder - Chair, HCV Action and Clinical Lead, Nottingham Hepatitis C ODN

This 2020 update on drug-related infectious diseases from the EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) aims to provide a comprehensive overview of the current situation with regard to the epidemiological picture of drug-related infectious diseases in Europe up to January 2020. It highlights some recent innovative responses to the problem and argues that early diagnosis through testing as well as improving links to treatment and care are crucial steps towards reaching global health goals.

This report from Public Health England breaks down the number of laboratory reports of hepatitis C tests carried out in England and Wales between October and December 2019 by age and gender. A breakdown is also provided by ODN in England.

Published in March 2020, this report from The King's Fund on health and care for people who sleep rough focusses on reducing barriers people face to accessing healthcare services and on commissioning appropriate services. The report argues that to improve health outcomes for people sleeping rough we need local authorities to team up with charities and community services; we need both a population health approach and a place-based approach; we need co-production with people with lived experience of sleeping rough; and we need staff working with this group to be properly recruited and supported.